Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.02 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 15 Parkinson's papers of 3,785 | 0.64 |
| pathways Reactome | 1 pathway; mostly protein handling | 0.90 |
No case: the score is under the bar. Receipt 7339
Sealed predictions
- ADO in dopamine neurons, braak+0.58 (p 0.102) → -0.06 (p 0.877)receipt 7347
Swarm cases
receipt 7347: ADO in dopamine neurons, braak
- power
- full sample +0.22 (p 0.379, n 18), 95% CI -0.27 to +0.62. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.24 (p 0.346, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.18 (p 0.465, n 18). could be the mix.
- skeptic
- leave-one-out range +0.12 to +0.40, sign flips 0; without severely affected donors +0.22 (p 0.379, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ADO in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts